Reverse Genetics of RNA Viruses 2012
DOI: 10.1002/9781118405338.ch10
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Modification in Mammalian Orthoreoviruses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 119 publications
0
4
0
Order By: Relevance
“…Viruses selected for their large-plaque phenotype using L929 cells, somewhat reminiscent of larger plaques formed by VeroAV on Vero cells in the absence of chymotrypsin, were shown to be better oncolytic viruses both in vitro and in animal models (Shmulevitz et al, 2012). A recent report (van den Wollenberg et al, 2012) also suggests that the ability to infect cells independently of the JAM receptor, possibly due to increased binding to sialic acids, could be a useful strategy against cancer cell types that express low levels of JAM and are thus relatively resistant to reovirus (van den Hengel et al, 2013;van den Wollenberg et al, 2009;van Houdt et al, 2008). Furthermore, a virus harboring a deletion of the JAM binding domain and binding solely onto cell surface sialic acids, was shown to be attenuated in nontransformed cells while retaining an oncolytic potential and exhibiting reduced host toxicity (Kim et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Viruses selected for their large-plaque phenotype using L929 cells, somewhat reminiscent of larger plaques formed by VeroAV on Vero cells in the absence of chymotrypsin, were shown to be better oncolytic viruses both in vitro and in animal models (Shmulevitz et al, 2012). A recent report (van den Wollenberg et al, 2012) also suggests that the ability to infect cells independently of the JAM receptor, possibly due to increased binding to sialic acids, could be a useful strategy against cancer cell types that express low levels of JAM and are thus relatively resistant to reovirus (van den Hengel et al, 2013;van den Wollenberg et al, 2009;van Houdt et al, 2008). Furthermore, a virus harboring a deletion of the JAM binding domain and binding solely onto cell surface sialic acids, was shown to be attenuated in nontransformed cells while retaining an oncolytic potential and exhibiting reduced host toxicity (Kim et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…This has led to numerous clinical studies as reviewed by others (Black and Morris, 2012;Clements et al, 2014;Harrington et al, 2010;Kelly et al, 2009;Maitra et al, 2012). Despite the fact that reoviruses are naturally oncolytic without prior genetic modifications, there is still a significant research effort ongoing to obtain novel virus variants better adapted to infect, replicate in, and kill cancer cells while sparing non-transformed cells (van den Hengel et al, 2013;Kim et al, 2011;Rudd and Lemay, 2005;Shmulevitz et al, 2012;van den Wollenberg et al, 2009van den Wollenberg et al, , 2012. One possible approach is to take advantage of novel viral variants that could be selected during establishment of viral persistence in different cell types.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This could possibly lead to better optimization of viral strains toward oncolytic activity, as many investigators believe to be possible, and as recently reviewed (Mohamed et al, 2015;Kemp et al, 2016). This is especially envisaged since the advent of plasmid-based reverse genetics to manipulate the viral genome (Lemay, 2011;van den Hengel et al, 2013;Stuart et al, 2017). In the present study, reverse genetics was thus used to introduce each of the T3D K gene in the T3D S genetic background, either separately or in different combinations, in order to determine which protein(s) is responsible for this difference in interferon response.…”
Section: Introductionmentioning
confidence: 99%